FIELD: pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and medicine. Method of producing dalfampridin pellets is disclosed, characterized by preparing intra-granulated mixture by screening dalfampridin together with hydroxypropyl methyl cellulose with viscosity of 80–120 MPA˙s, mixing with microcrystalline cellulose with particle size of 50–90 mcm and aerosil, compaction, mixing with magnesium stearate, it is followed by granulation of mixture by rolling, extra-granulated mixture is added to obtained granules consisting of microcrystalline cellulose with particle size of 50–90 mcm and aerosil, mixed to homogeneous state, magnesium stearate is added, tablets are pressed and coated with their shell by spraying water solution of white Opadraja till tablet weight increases by 1.0–3.0 %.
EFFECT: obtained solid shape has improved pharmacological and process characteristics.
6 cl, 1 dwg, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
CLOZAPINE TABLETS WITH DELAYED RELEASE AND METHOD OF OBTAINING THEREOF | 2015 |
|
RU2624229C2 |
PHARMACEUTICAL COMPOSITION FOR SLEEP DISORDERS PREVENTION AND TREATMENT | 2016 |
|
RU2620855C1 |
BIOTIN TABLETS WITH DELAYED RELEASE AND METHOD FOR OBTAINING THEREOF | 2016 |
|
RU2638803C2 |
TABLETS OF CLOZAPINE WITH SUSTAINED RELEASE | 2016 |
|
RU2613192C1 |
COMPOSITION FOR TREATING DISTURBED INNERVATION (VERSIONS) | 2013 |
|
RU2536269C1 |
PHARMACEUTICAL COMPOSITION CONTAINING BIOTIN AND METHOD FOR ITS PRODUCTION | 2017 |
|
RU2639488C1 |
PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL EFFECT AND METHOD OF ITS PREPARING | 2001 |
|
RU2190403C1 |
COMPOSITION COMPOSITE OF MEDICINAL AGENT AS ANTAGONIST OF SLOW CALCIUM CHANNELS | 1999 |
|
RU2188635C2 |
NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
TABLET CONTAINING CHOLESTEROL HYDROCHLORIDE AND METHOD FOR ITS PRODUCTION | 1992 |
|
RU2108090C1 |
Authors
Dates
2017-01-10—Published
2015-09-25—Filed